Neurobehavioral Manifestations  >>  memantine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT01261741 / 2010-020737-50: Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems

Completed
2
299
Europe
Memantine, Placebo
Merz Pharmaceuticals GmbH
Memory Disorder, Retention Disorder, Cognitive, Subjective Cognitive Impairment, Memory, Concentration or Attention Problems
08/11
09/11

Download Options